Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
2010 2
2011 1
2012 3
2013 3
2015 1
2017 2
2018 3
2019 3
2020 3
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases.
Thomas ML, Shaddick G, Charlton R, Cavill C, Holland R, Iannone F, Lapadula G, Lopriore S, Závada J, Uher M, Pavelka K, Szczuková L, Sidiropoulos P, Flouri I, Drosos A, Möller B, Nissen MJ, Müller RB, Scherer A, McHugh N, Nightingale A. Thomas ML, et al. Among authors: cavill c. J Rheumatol. 2021 Jan 1;48(1):48-57. doi: 10.3899/jrheum.190815. Epub 2020 Apr 1. J Rheumatol. 2021. PMID: 32238520
Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: reply.
Yahya F, Gaffney K, Hamilton L, Lonsdale E, Leeder J, Brooksby A, Cavill C, Berry-Jenkins J, Boyle C, Bond D, Sengupta R. Yahya F, et al. Among authors: cavill c. Rheumatol Adv Pract. 2018 Oct 18;2(2):rky037. doi: 10.1093/rap/rky037. eCollection 2018. Rheumatol Adv Pract. 2018. PMID: 31433399 Free PMC article. No abstract available.
Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis.
Allard A, Antony A, Shaddick G, Jadon DR, Cavill C, Robinson G, Korendowych E, McHugh N, Tillett W. Allard A, et al. Among authors: cavill c. Rheumatology (Oxford). 2019 Feb 1;58(2):269-273. doi: 10.1093/rheumatology/key297. Rheumatology (Oxford). 2019. PMID: 30247726
18 results